ZY15557

ZY15557 is a novel, competitive, long acting, orally active DPP-4 inhibitor, with a Ki of 5.53 nM. ZY15557 inhibits plasma DPP-4 activity. ZY15557 can be used in the research of type 2 diabetes[1].

Product Specifications

CAS Number

[1601480-12-9]

UNSPSC

12352005

Target

Dipeptidyl Peptidase

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Smiles

N[C@H]1C[C@@H](N2CC3=C(C2)CS(=O)(=O)C3)CO[C@@H]1C4=C(F)C=CC(F)=C4

Molecular Formula

C17H20F2N2O3S

Molecular Weight

370.41

References & Citations

[1]Jain MR, et al. ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus. Br J Pharmacol. 2017 Jul;174 (14) :2346-2357.